Egle Therapeutics

About:

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

Website: https://www.egle-tx.com

Top Investors: Bpifrance, EQT Life Sciences, Bioqube Ventures, Takeda Ventures, Fund+

Description:

Egle Therapeutics is an emerging biotechnology company focused on developing First-In-Class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases. The company was founded in 2020 and is based in Paris, France.

Total Funding Amount:

40M EUR

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2020-01-01

Contact Email:

contact(AT)egle-tx.com

Founders:

Eliane Piaggio, Luc Boblet

Number of Employees:

11-50

Last Funding Date:

2021-10-22

IPO Status:

Private

Industries: